Renal effects of BG9928, an A₁ adenosine receptor antagonist, in rats and nonhuman primates

This publication has 11 references indexed in Scilit:

• The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure
  Journal of the American College of Cardiology, 2002
• Adenosine A1 receptor antagonists in the kidney: effects in fluid-retaining disorders.
  Current Opinion in Pharmacology, 2002
• BG9719 (CVT-124), an A ₁ Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy
  Circulation, 2002
• Influence of progressive renal dysfunction in chronic heart failure
  European Journal of Heart Failure, 2002
• Renal Effects of Adenosine A1-Receptor Antagonists in Congestive Heart Failure
  Drugs, 2001
• Correlates and impact on outcomes of worsening renal function in patients ≥65 years of age with heart failure ∗
  The American Journal of Cardiology, 2000
• Natriuretic and Diuretic Actions of a Highly Selective Adenosine A1 Receptor Antagonist
  Journal of the American Society of Nephrology, 1999
• New concepts in the pathophysiology of heart failure: beneficial and deleterious interaction of endogenous haemodynamic and neurohormonal mechanisms
  Journal of Internal Medicine, 1996
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973